Prosecution Insights
Last updated: October 25, 2026
Application No. 18/394,541

PLASTICIZER, PLASTIC COMPOSITION, AND PLASTIC PRODUCT

Non-Final OA §102§103
Filed
Dec 22, 2023
Priority
Dec 22, 2022 — TW 111149575
Examiner
LEE, DORIS L
Art Unit
Tech Center
Assignee
Largan Medical Co. Ltd.
OA Round
1 (Non-Final)
59%
Grant Probability
Moderate
1-2
OA Rounds
3m
Est. Remaining
68%
With Interview

Examiner Intelligence

Grants 59% of resolved cases
59%
Career Allowance Rate
638 granted / 1086 resolved
-1.3% vs TC avg
Moderate +9% lift
Without
With
+8.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 1m
Avg Prosecution
42 currently pending
Career history
1135
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
57.5%
+17.5% vs TC avg
§102
15.3%
-24.7% vs TC avg
§112
13.8%
-26.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1086 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant's election with traverse of Group I (claims 1-11) in the reply filed on August 21, 2026 is acknowledged. The traversal is on the ground(s) that both the plasticizer of Invention I and Invention III have the same structure represented by Formula (I). This is not found persuasive because most notably, the plasticizer of Invention I does not have to be branched whereas the plasticizer of Invention III has a branched structure. As presently claimed, the two inventions require different search strategies. Claims 12-29 are withdrawn from further consideration pursuant to 37 CFR 1.142(b), as being drawn to a nonelected invention, there being no allowable generic or linking claim. The requirement is still deemed proper and is therefore made FINAL. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-3 and 6-11 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Klasson et al (WO 2019/172835). Regarding claim 1, Klasson teaches the following structure: PNG media_image1.png 96 135 media_image1.png Greyscale (page 60, structure I-34a) Which reads on the claimed Formula (1) where Xc and Yc are both 6. While Klasson does not explicitly teach that the compound is a plasticizer, it is noted that it is the exact same compound as presently recited and would inherently have the recited plasticizing and biodegradability characteristics. Regarding claims 2-3, Klasson teaches that the side chain structures are saturated and branched hydrocarbon chain structure. Regarding claim 6, the structure as taught by Klasson has a molecular weight of 301 g/mol. Regarding claims 7-10, given that the structure as taught by Klasson is the same composition as recited in the applicant’s Table 3A, it is noted that it would have the same properties as that composition. Therefore, the Pt is of the Klasson composition is 200 C, Dr14 is 12.06, Dr35 is 43.38 and Dr180 is 93.16 which satisfies the recited claims. Regarding claim 11, given that the structure as taught by Klasson is the same composition as recited in the applicant’s Table 3A, it is noted that it would have the same properties as that composition. Therefore, the cell viability is 81.90% at 0.3mM concentration which satisfies the recited claims. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1 and 4-5 is/are rejected under 35 U.S.C. 103 as being unpatentable over Chen (EP 3 825 354). Regarding claims 1 and 4-5, Chen teaches a plasticizer which is biodegradable (Abstract) which can have at its central moiety an aspartate amino acid ([0021]) and have side chains from 1 to 20 carbon atoms ([0027]). There can be two side chains and they can be different as evidenced by the examples. The side can have a polar group such as a hydroxyl group ([0033]). Chen fails to specifically exemplify the recited compound. However, it discloses each of the components of the compound and teaches that they are all suitable for use in the plasticizer. It is within the ordinary level of skill in the art to make any of the plasticizers as suggested by a reference, including selecting materials from a list in a reference. Therefore, a person of ordinary skill would have been motivated to prepare any of the compounds suggested by Chen, including the claimed plasticizer. In view of this, it would have been obvious to a person of ordinary skill in the art at the time of the present invention to use the teachings of Chen to arrive at the presently claimed invention. It would have been nothing more than using known compounds in a typical manner to achieve predictable results. KSR v. Teleflex, 550 U.S. 418, 82 USPQ2d 1385 (2007). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to DORIS L LEE whose telephone number is (571)270-3872. The examiner can normally be reached M-F 8 am - 5 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Arrie Lanee Reuther can be reached at 571-270-7026. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. DORIS L. LEE Primary Examiner Art Unit 1764 /DORIS L LEE/Primary Examiner, Art Unit 1764
Read full office action

Prosecution Timeline

Dec 22, 2023
Application Filed
Oct 09, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12767829
COLORANT, MASTER BATCH CONTAINING SAME, COLORED RESIN COMPOSITION, AND MOLDED ARTICLE
4y 0m to grant Granted Oct 20, 2026
Patent 12767797
ETHYLENE/ALPHA-OLEFIN INTERPOLYMER BASED COMPOSITIONS WITH EXCELLENT ADHESION PROPERTIES
3y 2m to grant Granted Oct 20, 2026
Patent 12753303
MODIFIED RESIN COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF
3y 3m to grant Granted Oct 06, 2026
Patent 12749931
FLEXIBLE STATOR FOR ELECTRIC MOTOR
4y 7m to grant Granted Sep 29, 2026
Patent 12747335
COMPOSITIONS FOR ELASTOMERIC COMPOUNDS COMPRISING TETRAZOLE COMPATIBILIZING AGENTS AND TYRES COMPRISING THE SAME
3y 9m to grant Granted Sep 29, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
59%
Grant Probability
68%
With Interview (+8.8%)
3y 1m (~3m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1086 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month